GlassScriptPhysician profile
Jaime D Kutter
NPI 1831247501
$4,775.28
in general payments reported to CMS, 2019-2025
35 companies · $1,164 in 2025
The $1,164 reported for 2025 was more than what 83% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $879 · 2022: $627 · 2023: $1,159 · 2024: $947 · 2025: $1,164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,190 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,189.60 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $980.96 | 2021-2025 | |
| Astellas Pharma US INC | $511.01 | 2021-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $485.65 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $367.60 | 2021-2025 | |
| Lilly USA, LLC | $359.32 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $353.33 | 2022-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $248.38 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $169.10 | 2022-2025 | Krystexxa, Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $123.26 | 2021-2025 | Spravato |
| Medtronic, INC. | $114.20 | 2024-2025 | Interstim, Intellis Adaptivestim |
| Teleflex LLC | $106.57 | 2024 | Urolift |
| Abbott Laboratories | $103.14 | 2023-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $90.63 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.19 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $73.37 | 2025 | Caplyta |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Kutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.